Cargando…

Infection-induced type I interferons critically modulate the homeostasis and function of CD8(+) naïve T cells

Naïve T (Tn) cells require two homeostatic signals for long-term survival: tonic T cell receptor:self-peptide–MHC contact and IL-7 stimulation. However, how microbial exposure impacts Tn homeostasis is still unclear. Here we show that infections can lead to the expansion of a subpopulation of long-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Jergović, Mladen, Coplen, Christopher P., Uhrlaub, Jennifer L., Besselsen, David G., Cheng, Shu, Smithey, Megan J., Nikolich-Žugich, Janko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421345/
https://www.ncbi.nlm.nih.gov/pubmed/34489451
http://dx.doi.org/10.1038/s41467-021-25645-w
Descripción
Sumario:Naïve T (Tn) cells require two homeostatic signals for long-term survival: tonic T cell receptor:self-peptide–MHC contact and IL-7 stimulation. However, how microbial exposure impacts Tn homeostasis is still unclear. Here we show that infections can lead to the expansion of a subpopulation of long-lived, Ly6C(+) CD8(+) Tn cells with accelerated effector function. Mechanistically, mono-infection with West Nile virus transiently, and polymicrobial exposure persistently, enhances Ly6C expression selectively on CD5(hi)CD8(+) cells, which in the case of polyinfection translates into a numerical CD8(+) Tn cell increase in the lymph nodes. This conversion and expansion of Ly6C(+) Tn cells depends on IFN-I, which upregulates MHC class I expression and enhances tonic TCR signaling in differentiating Tn cells. Moreover, for Ly6C(+)CD8(+ )Tn cells, IFN-I-mediated signals optimize their homing to secondary sites, extend their lifespan, and enhance their effector differentiation and antibacterial function, particularly for low-affinity clones. Our results thus uncover significant regulation of Tn homeostasis and function via infection-driven IFN-I, with potential implications for immunotherapy.